Jamie Moon
Overview
Explore the profile of Jamie Moon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
740
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Knarr M, Moon J, Rawat P, DiFeo A, Hoon D, Drapkin R
Sci Signal
. 2024 Nov;
17(863):eado8303.
PMID: 39561220
High-grade serous ovarian cancer (HGSOC) is one of the deadliest cancers for women, with a low survival rate, no early detection biomarkers, a high rate of recurrence, and few therapeutic...
2.
Goldfarb M, Bustos M, Moon J, Jackson K, Singer F, Hoon D
J Clin Endocrinol Metab
. 2024 Aug;
110(3):758-770.
PMID: 39163258
Context: The ability to differentiate sporadic primary hyperparathyroidism (sPHPT) caused by a single parathyroid adenoma (PTA) from multiglandular parathyroid disease (MGD) preoperatively, as well as definitely diagnose sPHPT in difficult...
3.
Pino J, Posso C, Joshi S, Nestor M, Moon J, Hansen J, et al.
Cell Rep Med
. 2024 Jan;
5(1):101359.
PMID: 38232702
Acute myeloid leukemia is a poor-prognosis cancer commonly stratified by genetic aberrations, but these mutations are often heterogeneous and fail to consistently predict therapeutic response. Here, we combine transcriptomic, proteomic,...
4.
Dou Y, Katsnelson L, Gritsenko M, Hu Y, Reva B, Hong R, et al.
Cancer Cell
. 2023 Aug;
41(9):1586-1605.e15.
PMID: 37567170
We characterized a prospective endometrial carcinoma (EC) cohort containing 138 tumors and 20 enriched normal tissues using 10 different omics platforms. Targeted quantitation of two peptides can predict antigen processing...
5.
Gosline S, Tognon C, Nestor M, Joshi S, Modak R, Damnernsawad A, et al.
Clin Proteomics
. 2022 Jul;
19(1):30.
PMID: 35896960
Acute Myeloid Leukemia (AML) affects 20,000 patients in the US annually with a five-year survival rate of approximately 25%. One reason for the low survival rate is the high prevalence...
6.
Koh Y, Bustos M, Moon J, Gross R, Ramos R, Ryu S, et al.
Cancers (Basel)
. 2022 May;
14(10).
PMID: 35625992
Prostate cancer (PCa) is the most common cancer in men. Prostate-specific antigen screening is recommended for the detection of PCa. However, its specificity is limited. Thus, there is a need...
7.
Jiang W, Wen B, Li K, Zeng W, Veiga Leprevost F, Moon J, et al.
Mol Cell Proteomics
. 2021 Nov;
20:100171.
PMID: 34737085
Tandem mass spectrometry (MS/MS)-based phosphoproteomics is a powerful technology for global phosphorylation analysis. However, applying four computational pipelines to a typical mass spectrometry (MS)-based phosphoproteomic dataset from a human cancer...
8.
Joshi S, Nechiporuk T, Bottomly D, Piehowski P, Reisz J, Pittsenbarger J, et al.
Cancer Cell
. 2021 Jun;
39(7):999-1014.e8.
PMID: 34171263
Our study details the stepwise evolution of gilteritinib resistance in FLT3-mutated acute myeloid leukemia (AML). Early resistance is mediated by the bone marrow microenvironment, which protects residual leukemia cells. Over...
9.
Wang L, Karpova A, Gritsenko M, Kyle J, Cao S, Li Y, et al.
Cancer Cell
. 2021 Feb;
39(4):509-528.e20.
PMID: 33577785
Glioblastoma (GBM) is the most aggressive nervous system cancer. Understanding its molecular pathogenesis is crucial to improving diagnosis and treatment. Integrated analysis of genomic, proteomic, post-translational modification and metabolomic data...
10.
Petralia F, Tignor N, Reva B, Koptyra M, Chowdhury S, Rykunov D, et al.
Cell
. 2020 Nov;
183(7):1962-1985.e31.
PMID: 33242424
We report a comprehensive proteogenomics analysis, including whole-genome sequencing, RNA sequencing, and proteomics and phosphoproteomics profiling, of 218 tumors across 7 histological types of childhood brain cancer: low-grade glioma (n ...